Related Experiment Video
Updated: Feb 26, 2026
06:15
Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
1.5K
Endotype-driven treatment in chronic upper airway diseases
Glynnis De Greve1, Peter W Hellings1,2,3, Wytske J Fokkens2
1Department of Otorhinolaryngology-Head and Neck Surgery, UZ Leuven, Louvain, Belgium.
Clinical and Translational Allergy
|July 15, 2017
Summary
Rhinitis and chronic rhinosinusitis impact millions, presenting diverse endotypes and inflammation patterns. Emerging precision medicine approaches target these specific pathways for personalized treatment of upper airway diseases.
Area of Science:
- Upper airway diseases
- Immunology
- Otolaryngology
Background:
- Rhinitis and chronic rhinosinusitis (CRS) are prevalent upper airway diseases with significant socio-economic impact.
- Distinct phenotypes exist for CRS and allergic rhinitis (AR), influenced by symptoms, atopy, control, comorbidities, and nasal polyps.
- Diverse pathophysiological mechanisms lead to various endotypes, including Type 2 inflammation (AR, CRSwNP), Type 1 inflammation (infectious rhinitis, CRSsNP), and neurogenic endotypes.
Purpose of the Study:
- To provide a comprehensive overview of endotypes, biomarkers, and targeted treatments for chronic inflammatory nose and paranasal sinus conditions.
- To highlight the shift towards precision medicine in managing rhinitis and CRS.
- To discuss the importance of patient selection for endotype-driven therapies.
Main Methods:
- Literature review of current research on rhinitis and CRS endotypes.
- Analysis of pathophysiological mechanisms and inflammatory pathways.
- Examination of emerging targeted therapies and personalized medicine approaches.
Main Results:
- Identification of key endotypes in rhinitis and CRS, including Type 2, Type 1, and neurogenic inflammation.
- Recognition of epithelial barrier dysfunction in AR and CRSwNP.
- Emerging therapies are increasingly focused on specific endotypes and pathways.
Conclusions:
- Understanding endotypes is crucial for developing effective, targeted treatments for rhinitis and CRS.
- Precision medicine, through endotype-driven approaches, offers a promising future for personalized patient care.
- Further research into biomarkers and targeted therapies is essential for advancing the management of these chronic conditions.
Related Concept Videos
01:16Drugs Used in Upper Respiratory Disorders: Overview
795
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
795
01:23Chronic Pharyngitis
13.3K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
13.3K
01:20Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:26Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.3K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.3K